MCID: PHR004
MIFTS: 49

Pharynx Cancer

Categories: Cancer diseases, Gastrointestinal diseases, Oral diseases

Aliases & Classifications for Pharynx Cancer

MalaCards integrated aliases for Pharynx Cancer:

Name: Pharynx Cancer 12 15
Pharyngeal Neoplasms 44 73
Pharyngeal Cancer 12 55
Malignant Neoplasm of Pharynx 73
Pharyngeal Carcinoma 73
Pharyngeal Neoplasm 12
Pharynx Neoplasm 12

Classifications:



External Ids:

Disease Ontology 12 DOID:0060119
MeSH 44 D010610
NCIt 50 C3325
SNOMED-CT 68 95001001

Summaries for Pharynx Cancer

Disease Ontology : 12 A gastrointestinal system cancer that is located in the pharynx.

MalaCards based summary : Pharynx Cancer, also known as pharyngeal neoplasms, is related to pharynx squamous cell carcinoma and oropharynx cancer. An important gene associated with Pharynx Cancer is FAM3D-AS1 (FAM3D Antisense RNA 1), and among its related pathways/superpathways are Human cytomegalovirus infection and Endometrial cancer. The drugs Ethanol and Fluorouracil have been mentioned in the context of this disorder. Affiliated tissues include lung, skin and brain, and related phenotypes are Decreased viability and Decreased viability

Related Diseases for Pharynx Cancer

Diseases in the Pharynx Cancer family:

Pharynx Carcinoma in Situ

Diseases related to Pharynx Cancer via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 146)
# Related Disease Score Top Affiliating Genes
1 pharynx squamous cell carcinoma 32.0 AKT1 SMUG1
2 oropharynx cancer 31.2 ACCS ADH1C CCND1 CD6 CDH1 CDKN2A
3 nasopharyngeal carcinoma 31.0 AKT1 BPIFA1 BRD7 CCND1 CDH1 CDKN2A
4 oral cancer 29.5 ADH1C CCND1 CDH1 CDKN2A EGFR GSTM1
5 alcohol dependence 11.1
6 hypopharynx cancer 11.1
7 breast papillomatosis 10.3 CCND1 CDKN2A
8 brain ependymoma 10.3 EGFR TP53
9 bartholin's duct cyst 10.3 SMUG1 TP53
10 oral leukoplakia 10.3 CDKN2A GSTM1 TP53
11 rare adenocarcinoma of the breast 10.3 AKT1 TP53
12 tonsil squamous cell carcinoma 10.3 CCND1 CDKN2A
13 middle ear carcinoma 10.3 MMP9 SMUG1
14 cerebral convexity meningioma 10.3 CDH1 TP53
15 verrucous carcinoma 10.3 CCND1 CDKN2A TP53
16 anal squamous cell carcinoma 10.3 AKT1 CDKN2A TP53
17 necrotizing sialometaplasia 10.3 CDKN2A KIT TP53
18 mutagen sensitivity 10.3 CCND1 GSTM1 TP53
19 anus cancer 10.3 CD6 CDKN2A SMUG1
20 malignant spiradenoma 10.3 SMUG1 TP53
21 cholecystitis 10.3 CDH1 CDKN2A TP53
22 inverted papilloma 10.3 CCND1 CDKN2A TP53
23 basaloid squamous cell carcinoma 10.3 CDKN2A EGFR TP53
24 pleural cancer 10.3 AKT1 CDKN2A SMUG1
25 retinal cancer 10.3 CCND1 CDKN2A TP53
26 cervical squamous cell carcinoma 10.3 CDH1 CDKN2A TP53
27 vulva cancer 10.3 CDKN2A EGFR TP53
28 cellular ependymoma 10.3 SMUG1 TP53
29 polymorphous low-grade adenocarcinoma 10.3 CCND1 KIT NFIB
30 bile duct adenocarcinoma 10.3 AKT1 CDH1 TP53
31 ocular cancer 10.3 CCND1 CDKN2A TP53
32 protoplasmic astrocytoma 10.3 SMUG1 TP53
33 ovarian cancer 1 10.2 AKT1 CDH1 TP53
34 hidradenocarcinoma 10.2 CCND1 EGFR TP53
35 malignant ovarian surface epithelial-stromal neoplasm 10.2 AKT1 CDH1 TP53
36 ovary epithelial cancer 10.2 AKT1 CDH1 TP53
37 thymus gland disease 10.2 AKT1 KIT SMUG1
38 keratocystic odontogenic tumor 10.2 CCND1 MMP9 TP53
39 bladder squamous cell carcinoma 10.2 CDKN2A TP53
40 skin melanoma 10.2 CDKN2A MMP9 TP53
41 thymus cancer 10.2 KIT SMUG1 TP53
42 malignant peritoneal mesothelioma 10.2 CDKN2A EGFR
43 adenosquamous carcinoma 10.2 EGFR KIT TP53
44 tongue disease 10.2 CD6 CDH1 CDKN2A TP53
45 colorectal adenocarcinoma 10.2 CDH1 EGFR TP53
46 chordoma 10.2 CDH1 CDKN2A EGFR
47 upper respiratory tract disease 10.2 CDKN2A TMEM8B TP53
48 inflammatory myofibroblastic tumor 10.2 CCND1 KIT TP53
49 salivary gland carcinoma 10.2 CDKN2A EGFR KIT
50 acute lymphocytic leukemia 10.2 CDKN2A GSTM1 TP53

Comorbidity relations with Pharynx Cancer via Phenotypic Disease Network (PDN):


Deficiency Anemia Larynx Cancer
Protein-Energy Malnutrition Swallowing Disorders

Graphical network of the top 20 diseases related to Pharynx Cancer:



Diseases related to Pharynx Cancer

Symptoms & Phenotypes for Pharynx Cancer

GenomeRNAi Phenotypes related to Pharynx Cancer according to GeneCards Suite gene sharing:

26
# Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Decreased viability GR00055-A-2 9.6 EGFR
2 Decreased viability GR00221-A-1 9.6 AKT1 CDH1 CDKN2A EGFR KIT
3 Decreased viability GR00221-A-2 9.6 AKT1
4 Decreased viability GR00221-A-3 9.6 AKT1 CDKN2A
5 Decreased viability GR00221-A-4 9.6 AKT1 CDKN2A EGFR
6 Decreased viability GR00301-A 9.6 CDH1 KIT
7 Decreased viability GR00402-S-2 9.6 AKT1 CDH1 CDKN2A EGFR KIT

MGI Mouse Phenotypes related to Pharynx Cancer:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 growth/size/body region MP:0005378 10.15 ADH1C AKT1 B4GALT5 BRD7 CCND1 CDH1
2 homeostasis/metabolism MP:0005376 10.13 ADH1C AKT1 B4GALT5 CCND1 CD6 CDH1
3 digestive/alimentary MP:0005381 10.01 CCND1 CDH1 CDKN2A EGFR KIT MMP9
4 mortality/aging MP:0010768 10 ADH1C AKT1 B4GALT5 BPIFA1 BRD7 CCND1
5 integument MP:0010771 9.91 AKT1 BRD7 CCND1 CDH1 CDKN2A EGFR
6 neoplasm MP:0002006 9.61 AKT1 CCND1 CDH1 CDKN2A EGFR KIT
7 respiratory system MP:0005388 9.28 AKT1 BPIFA1 CCND1 CDKN2A EGFR KIT

Drugs & Therapeutics for Pharynx Cancer

Drugs for Pharynx Cancer (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 64)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Ethanol Approved Phase 3 64-17-5 702
2
Fluorouracil Approved Phase 3,Phase 2 51-21-8 3385
3
Hydroxyurea Approved Phase 3,Phase 2 127-07-1 3657
4
Cisplatin Approved Phase 3,Phase 2,Phase 1,Early Phase 1 15663-27-1 2767 441203 84093
5
Docetaxel Approved, Investigational Phase 3,Phase 2 114977-28-5 148124
6 Nucleic Acid Synthesis Inhibitors Phase 3,Phase 2
7 Antimitotic Agents Phase 3
8 Immunosuppressive Agents Phase 3,Phase 2,Phase 1
9 Immunologic Factors Phase 3,Phase 2,Phase 1
10 Antimetabolites, Antineoplastic Phase 3,Phase 2
11 Antimetabolites Phase 3,Phase 2
12
Cetuximab Approved Phase 2,Phase 1 205923-56-4 56842117 2333
13
Celecoxib Approved, Investigational Phase 1, Phase 2 169590-42-5 2662
14
Ifosfamide Approved Phase 2 3778-73-2 3690
15
Doxorubicin Approved, Investigational Phase 2 23214-92-8 31703
16
Mechlorethamine Approved, Investigational Phase 2 51-75-2 4033
17
Doxil Approved June 1999 Phase 2 31703
18 Anti-Inflammatory Agents, Non-Steroidal Phase 1, Phase 2
19 Cyclooxygenase 2 Inhibitors Phase 1, Phase 2
20 Analgesics Phase 1, Phase 2
21
Erlotinib Hydrochloride Phase 1, Phase 2,Early Phase 1 183319-69-9 176871
22 Anti-Inflammatory Agents Phase 1, Phase 2
23 Cyclooxygenase Inhibitors Phase 1, Phase 2
24 Protein Kinase Inhibitors Phase 1, Phase 2,Early Phase 1
25 Peripheral Nervous System Agents Phase 1, Phase 2,Not Applicable
26 Mitogens Phase 1, Phase 2,Early Phase 1
27 Antirheumatic Agents Phase 1, Phase 2
28 Analgesics, Non-Narcotic Phase 1, Phase 2
29 Anti-Bacterial Agents Phase 2,Phase 1
30 Antibiotics, Antitubercular Phase 2,Phase 1
31 Antineoplastic Agents, Alkylating Phase 2
32
Isophosphamide mustard Phase 2 0
33 Alkylating Agents Phase 2
34 Topoisomerase Inhibitors Phase 2
35
Bortezomib Approved, Investigational Phase 1 179324-69-7 387447 93860
36
Bevacizumab Approved, Investigational Phase 1,Early Phase 1 216974-75-3
37
Sirolimus Approved, Investigational Phase 1 53123-88-9 46835353 6436030 5284616
38
Everolimus Approved Phase 1 159351-69-6 6442177
39
Valproic Acid Approved, Investigational Phase 1 99-66-1 3121
40
Miconazole Approved, Investigational, Vet_approved Phase 1 22916-47-8 4189
41 Endothelial Growth Factors Phase 1,Early Phase 1
42 Angiogenesis Modulating Agents Phase 1,Early Phase 1
43 Neurotransmitter Agents Phase 1,Not Applicable
44 Angiogenesis Inhibitors Phase 1,Early Phase 1
45 Immunoglobulin G Phase 1
46 GABA Agents Phase 1
47 Psychotropic Drugs Phase 1
48 Central Nervous System Depressants Phase 1
49 Tranquilizing Agents Phase 1
50 Antifungal Agents Phase 1

Interventional clinical trials:

(show all 26)
# Name Status NCT ID Phase Drugs
1 Docetaxel Based Chemotherapy Plus or Minus Induction Chemotherapy to Decrease Events in Head and Neck Cancer (DeCIDE) Completed NCT00117572 Phase 3 docetaxel;cisplatin;hydroxyurea;fluorouracil
2 Randomized Trial to Assess the Impact of a Screening Program on Upper Aerodigestive Tract Cancer Mortality in a High Risk Population Completed NCT00359645 Phase 3
3 Concurrent Chemoradiation Versus Surgery With Adjuvant Therapy in Advanced Laryngopharyngeal Cancers Terminated NCT00128817 Phase 3
4 Radiotherapy With Cisplatin Versus Radiotherapy With Cetuximab After Induction Chemotherapy for Larynx Preservation Completed NCT00169247 Phase 2 cetuximab;Cisplatin
5 Resistance Training During Radiation Therapy for Pharyngeal or Laryngeal Cancer Completed NCT00827164 Phase 2
6 Erlotinib, Celecoxib and Reirradiation for Recurrent Head and Neck Cancer Completed NCT00970502 Phase 1, Phase 2 erlotinib + celecoxib
7 Fluorouracil, Hydroxyurea, Cetuximab and Twice-daily Intensity Radiation Therapy for Advanced Head and Neck Cancer Completed NCT00462735 Phase 2 Cetuximab;Hydroxyurea;Fluorouracil
8 Combination of Cryosurgey and NK Immunotherapy for Recurrent Pharyngeal Cancer Recruiting NCT02849327 Phase 1, Phase 2
9 Nivolumab and Ipilimumab and Stereotactic Body Radiation Therapy in Treating Patients With Salivary Gland Cancers Not yet recruiting NCT03749460 Phase 1, Phase 2
10 Ifosfamide and Doxorubicin in Patients With Refractory Nasopharyngeal Carcinoma Terminated NCT00484601 Phase 2 Ifosfamide; Doxorubicin
11 Resistance Training and Physical Functioning in Head and Neck Cancer Patients Completed NCT01332682 Phase 1
12 Radiation Therapy and Bortezomib and Cetuximab With or Without Cisplatin to Treat Head and Neck Cancer Completed NCT01445405 Phase 1 Bortezomib (Velcade, PS-341);Cetuximab;Cisplatin
13 Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease Recruiting NCT01552434 Phase 1 Temsirolimus;Valproic Acid
14 Study of Blood and Tissue Samples From Patients With Larynx Cancer, Pharynx Cancer, or Oral Cavity Cancer Unknown status NCT00963326
15 Carcinologic Speech Severity Index Unknown status NCT02875795 Not Applicable
16 Natural History of Oro-pharyngeal Cancer Precursors Completed NCT00179361
17 Angiogenic and EGFR Blockade With Curative Chemoradiation for Advanced Head and Neck Cancer Completed NCT00140556 Early Phase 1 Cisplatin;Bevacizumab;Erlotinib
18 Improvement in Knowledge and Perception About Hazards of Smokeless Tobacco Completed NCT03418506 Not Applicable
19 Comparison Between a Standard Tube and the Ultra-thin Tritube for Intubation of the Trachea and for Maintaining Access to the Trachea After Anaesthesia, in Patients With an Expected Difficult Direct Laryngoscopy Recruiting NCT03653039 Not Applicable
20 Screening for Cancers in the Oral CAvity Recruiting NCT01958762 Not Applicable
21 The Clinical Relevance of P16 Expressing CTCs Detection Comparing With HPV Infection in Cancer Tissue in HNSCC Patients. Recruiting NCT02791607
22 Nicotine Levels With Response Rates to Radiation Alone or With Chemo In Head & Neck Cancer Recruiting NCT01084733
23 Patient Evaluation for Head and Neck Surgery Branch Studies Recruiting NCT00011492
24 Pilot Study to Improve Therapeutic Outcomes for Dysphagia After Radiation Therapy Active, not recruiting NCT02564887 Not Applicable
25 Use of Human Dehydrated Amnion Chorion Allograft in Laryngectomy/Pharyngectomy Enrolling by invitation NCT03479463
26 Oropharyngeal Function After Radiotherapy With IMRT Terminated NCT00506324

Search NIH Clinical Center for Pharynx Cancer

Cochrane evidence based reviews: pharyngeal neoplasms

Genetic Tests for Pharynx Cancer

Anatomical Context for Pharynx Cancer

MalaCards organs/tissues related to Pharynx Cancer:

41
Lung, Skin, Brain, Bone, Colon, Tongue, Tonsil

The Foundational Model of Anatomy Ontology organs/tissues related to Pharynx Cancer:

19
The Pharynx

Publications for Pharynx Cancer

Articles related to Pharynx Cancer:

(show all 18)
# Title Authors Year
1
Inaccuracies in oral cavity-pharynx cancer coded as the underlying cause of death on U.S. death certificates, and trends in mortality rates (1999-2010). ( 24862544 )
2014
2
Oral cavity and pharynx cancer incidence trends by subsite in the United States: changing gender patterns. ( 22577381 )
2012
3
Incidence of oral cavity and pharynx cancer in New Hampshire, 1990-2007. ( 23493023 )
2012
4
Comparison of time trends in lip, oral cavity and pharynx cancer mortality (1990-2006) between countries based on the WHO mortality database. ( 20978186 )
2010
5
Incidence of oral cavity and pharynx cancer in Kentucky. ( 18783038 )
2008
6
Late swallowing dysfunction and dysphagia after radiotherapy for pharynx cancer: frequency, intensity and correlation with dose and volume parameters. ( 17673322 )
2007
7
Measuring side effects after radiotherapy for pharynx cancer. ( 17882557 )
2007
8
Recovery issues for African Americans following treatment of oral cavity/pharynx cancer. ( 16841807 )
2006
9
Stat bite: Incidence of and mortality from oral cavity and pharynx cancer, 1975-2002. ( 16418507 )
2006
10
Oral cavity and pharynx cancer incidence rates in the United States, 1975-1998. ( 12167440 )
2002
11
The epidemiology of oral and pharynx cancer in Brazil. ( 12570051 )
2002
12
Pattern recognition analysis to the variation of nasal-pharynx cancer patients' trace element levels in samples of hair, whole blood, and tissue. ( 7986657 )
1994
13
Dosimetric intercomparison in the British Institute of Radiology fractionation study of 3F/week versus 5F/week in radiotherapy of laryngo-pharynx cancer. ( 2178720 )
1990
14
Indirect videolaryngoscopy versus direct endoscopy for larynx and pharynx cancer staging. Toward elimination of preliminary direct laryngoscopy. ( 2782803 )
1989
15
Complications associated with combined therapy of oral and pharyngeal neoplasms. ( 5055082 )
1972
16
The biological behaviour of canine oral and pharyngeal neoplasms. ( 5531088 )
1970
17
Survivorship with mouth and pharynx cancer and their association with cirrhosis of the liver, marital status, and residence. ( 5815753 )
1969
18
EPIDEMIOLOGIC ASPECTS OF ORAL AND PHARYNGEAL NEOPLASMS OF THE DOG. ( 14227189 )
1964

Variations for Pharynx Cancer

Expression for Pharynx Cancer

Search GEO for disease gene expression data for Pharynx Cancer.

Pathways for Pharynx Cancer

Pathways related to Pharynx Cancer according to GeneCards Suite gene sharing:

(show all 44)
# Super pathways Score Top Affiliating Genes
1
Show member pathways
13.02 AKT1 CCND1 CDKN2A EGFR MMP9 TP53
2
Show member pathways
12.72 AKT1 CCND1 CDH1 CDKN2A EGFR KIT
3
Show member pathways
12.65 AKT1 CCND1 CDH1 CDKN2A EGFR MMP9
4 12.48 CCND1 CDKN2A EGFR MMP9 TP53
5
Show member pathways
12.47 AKT1 CCND1 CDH1 EGFR MMP9 TP53
6
Show member pathways
12.44 AKT1 CCND1 EGFR TP53
7 12.39 AKT1 CCND1 CDH1 TP53
8
Show member pathways
12.39 CCND1 CDKN2A EGFR KIT
9 12.38 AKT1 CCND1 CDKN2A TP53
10 12.38 AKT1 CCND1 CDH1 CDKN2A EGFR GSTM1
11 12.33 CCND1 CDH1 CDKN2A TP53
12 12.24 AKT1 CCND1 EGFR MMP9 TP53
13
Show member pathways
12.17 AKT1 CCND1 EGFR TP53
14 12.12 AKT1 CCND1 CDKN2A TP53
15 12.09 AKT1 CCND1 EGFR TP53
16 12.08 AKT1 CCND1 CDH1 EGFR TP53
17 12 AKT1 GSTM1 GSTM3 MMP9 TP53
18
Show member pathways
11.99 AKT1 BRD7 CCND1 CDH1 CDKN2A EGFR
19 11.97 CCND1 EGFR MMP9 TP53
20 11.95 AKT1 CCND1 CDH1 EGFR MMP9 TP53
21 11.93 AKT1 CCND1 CDKN2A TP53
22 11.92 AKT1 CCND1 MMP9 TP53
23 11.85 AKT1 CCND1 CDKN2A EGFR TP53
24 11.83 AKT1 CCND1 TP53
25 11.82 AKT1 CCND1 EGFR
26 11.75 CCND1 CDH1 MMP9
27 11.74 CCND1 GSTM1 KIT
28
Show member pathways
11.7 AKT1 CDKN2A TP53
29 11.65 AKT1 EGFR MMP9
30 11.65 AKT1 NFIB TP53
31 11.64 AKT1 CCND1 EGFR
32 11.64 AKT1 EGFR KIT TP53
33 11.63 AKT1 EGFR MMP9
34
Show member pathways
11.58 AKT1 CCND1 EGFR MMP9
35 11.58 AKT1 CDKN2A GSTM1 GSTM3 TP53
36 11.54 AKT1 CCND1 TP53
37 11.51 AKT1 CCND1 TP53
38 11.5 CCND1 CDH1 CDKN2A EGFR MMP9 TP53
39 11.49 CCND1 CDKN2A EGFR TP53
40 11.47 AKT1 CDH1 MMP9
41
Show member pathways
11.44 AKT1 BRD7 TP53
42 11.29 AKT1 CCND1 CDH1
43 11.24 AKT1 CDH1 EGFR
44 11 AKT1 CDH1 EGFR

GO Terms for Pharynx Cancer

Biological processes related to Pharynx Cancer according to GeneCards Suite gene sharing:

(show all 17)
# Name GO ID Score Top Affiliating Genes
1 positive regulation of transcription, DNA-templated GO:0045893 9.88 AKT1 BRD7 CDH1 CDKN2A EGFR TP53
2 response to organic substance GO:0010033 9.74 AKT1 CCND1 CDH1
3 positive regulation of protein phosphorylation GO:0001934 9.73 AKT1 CCND1 EGFR MMP9
4 regulation of signal transduction by p53 class mediator GO:1901796 9.71 AKT1 BRD7 TP53
5 replicative senescence GO:0090399 9.56 CDKN2A TP53
6 tongue development GO:0043586 9.55 EGFR KIT
7 somatic stem cell division GO:0048103 9.52 CDKN2A KIT
8 positive regulation of production of miRNAs involved in gene silencing by miRNA GO:1903800 9.51 EGFR TP53
9 cellular response to cadmium ion GO:0071276 9.5 AKT1 EGFR MMP9
10 mitotic G1 DNA damage checkpoint GO:0031571 9.49 CCND1 TP53
11 obsolete positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle GO:0031659 9.48 AKT1 EGFR
12 xenobiotic catabolic process GO:0042178 9.46 GSTM1 GSTM3
13 cellular response to reactive oxygen species GO:0034614 9.43 AKT1 EGFR MMP9
14 nitrobenzene metabolic process GO:0018916 9.37 GSTM1 GSTM3
15 cytokine-mediated signaling pathway GO:0019221 9.35 AKT1 CCND1 KIT MMP9 TP53
16 cellular detoxification of nitrogen compound GO:0070458 9.16 GSTM1 GSTM3
17 response to UV-A GO:0070141 8.8 AKT1 CCND1 EGFR

Molecular functions related to Pharynx Cancer according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 protein homodimerization activity GO:0042803 9.8 ACCS AKT1 CDH1 GSTM1 GSTM3 KIT
2 identical protein binding GO:0042802 9.56 ACCS AKT1 CD6 CDH1 EGFR GSTM3
3 protein kinase binding GO:0019901 9.55 AKT1 CCND1 CDKN2A EGFR TP53
4 GTPase activating protein binding GO:0032794 9.4 AKT1 CDH1
5 glutathione binding GO:0043295 9.37 GSTM1 GSTM3
6 nitric-oxide synthase regulator activity GO:0030235 9.26 AKT1 EGFR
7 enzyme binding GO:0019899 9.1 AKT1 CCND1 EGFR GSTM1 GSTM3 TP53

Sources for Pharynx Cancer

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....